Atypical Hemolytic Uremic Syndrome
Is Soliris Effective in aHUS with Complement-Amplifying Conditions?
New Data Shows Soliris Provides Reduction in Post-Transplant Dialysis in aHUS Patients
Alexion Begins 2 Phase 3 trials for 2 Rare Diseases
Do You Want to Be a Rare Disease Superhero?
Spotlight on aHUS
Canada Says No To Alexion's aHUS Orphan Drug
Kidney Week 2015: Long-Term Data with Soliris (eculizumab) is Impressive
Anti-aHUS Bio-therapy Fast-Tracked
Anti-aHUS Bio-therapy Closing in on Marketplace Approval
Brief Overview of Atypical Hemolytic Uremic Syndrome
Does Eculizumab Play a Role in Treating Pregnancy-Associated Atypical Hemolytic-Uremic Syndrome?
Multiple Soliris Trials to Treat aHUS Presented at Nephrology Meeting
Next Page >>
MOST POPULAR ARTICLES
Q&A with Hartmann Wellhoefer, Shire's VP and Head of Medical Affairs; Rare Diseases & Internal Medicine
FDA Approves Hydroxyurea Tablets for Pediatric Sickle Cell Anemia
Does Michael Phelps Have Marfan Syndrome?
FDA Approval Granted to CIDP Treatment
STRATEGIC ALLIANCE PARTNERSHIP PROGRAM >
Familial Chylomicronemia Syndrome
MJH ASSOCIATES >
Specialty Pharmacy Times
Terms & Conditions
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.